[HTML][HTML] Treatment sequencing in metastatic colorectal cancer
DP Modest, S Pant, A Sartore-Bianchi - European Journal of Cancer, 2019 - Elsevier
Metastatic colorectal cancer (mCRC) remains incurable in most cases, but survival has
improved with advances in cytotoxic chemotherapy and targeted agents. However, the …
improved with advances in cytotoxic chemotherapy and targeted agents. However, the …
Treatment sequencing in metastatic colorectal cancer
DP Modest, S Pant, A Sartore-Bianchi - European Journal of Cancer, 2019 - Elsevier
Metastatic colorectal cancer (mCRC) remains incurable in most cases, but survival has
improved with advances in cytotoxic chemotherapy and targeted agents. However, the …
improved with advances in cytotoxic chemotherapy and targeted agents. However, the …
[引用][C] Treatment sequencing in metastatic colorectal cancer
DP Modest, S Pant, A Sartore-Bianchi - European Journal of Cancer, 2019 - cir.nii.ac.jp
Treatment sequencing in metastatic colorectal cancer
DP Modest, S Pant… - European journal of …, 2019 - pubmed.ncbi.nlm.nih.gov
Metastatic colorectal cancer (mCRC) remains incurable in most cases, but survival has
improved with advances in cytotoxic chemotherapy and targeted agents. However, the …
improved with advances in cytotoxic chemotherapy and targeted agents. However, the …
Treatment sequencing in metastatic colorectal cancer
DP Modest, S Pant… - European Journal of …, 2019 - epub.ub.uni-muenchen.de
Metastatic colorectal cancer (mCRC) remains incurable in most cases, but survival has
improved with advances in cytotoxic chemotherapy and targeted agents. However, the …
improved with advances in cytotoxic chemotherapy and targeted agents. However, the …
Treatment sequencing in metastatic colorectal cancer.
DP Modest, S Pant, A Sartore-Bianchi - European Journal of Cancer …, 2019 - europepmc.org
Metastatic colorectal cancer (mCRC) remains incurable in most cases, but survival has
improved with advances in cytotoxic chemotherapy and targeted agents. However, the …
improved with advances in cytotoxic chemotherapy and targeted agents. However, the …
Treatment sequencing in metastatic colorectal cancer
DP Modest, S Pant… - … Journal of Cancer, 2019 - mdanderson.elsevierpure.com
Metastatic colorectal cancer (mCRC) remains incurable in most cases, but survival has
improved with advances in cytotoxic chemotherapy and targeted agents. However, the …
improved with advances in cytotoxic chemotherapy and targeted agents. However, the …
[PDF][PDF] TREATMENT SEQUENCING IN METASTATIC COLORECTAL CANCER
EUROPEAN JOURNAL OF CANCER, 2019 - cor2ed.com
Présentation PowerPoint Page 1 TREATMENT SEQUENCING IN METASTATIC COLORECTAL
CANCER EUROPEAN JOURNAL OF CANCER 109 (2019) 70-83 DP MODEST,1 S. PANT,2 …
CANCER EUROPEAN JOURNAL OF CANCER 109 (2019) 70-83 DP MODEST,1 S. PANT,2 …
Treatment sequencing in metastatic colorectal cancer
DP Modest, S Pant, A Sartore-Bianchi - EUROPEAN JOURNAL OF …, 2019 - air.unimi.it
Metastatic colorectal cancer (mCRC) remains incurable in most cases, but survival has
improved with advances in cytotoxic chemotherapy and targeted agents. However, the …
improved with advances in cytotoxic chemotherapy and targeted agents. However, the …
Treatment sequencing in metastatic colorectal cancer
DP Modest, S Pant, A Sartore-Bianchi - European Journal of Cancer, 2019 - ejcancer.com
Metastatic colorectal cancer (mCRC) remains incurable in most cases, but survival has
improved with advances in cytotoxic chemotherapy and targeted agents. However, the …
improved with advances in cytotoxic chemotherapy and targeted agents. However, the …